↩ Go Back
Need help?

Profitable Medical Imaging Systems Company Investment Opportunity in Massachusetts, United States

Company based in the US that designs, engineers and manufactures revolutionary medical devices.
This Business is on a Premium Plan
Established 10-20 year(s)
Employees 5 - 10
Legal Entity C Corporation
Reported Sales USD 50 thousand
Run Rate Sales USD 180 thousand
EBITDA Margin 50 %
Industries Medical Imaging Systems + 1 more
Locations  Massachusetts
Local Time 12:10 PM US / Eastern
Listed By Business Owner / Director
Status Active
Overall Rating
Partial Stake Sale
USD 500 thousand for 20.0% stake (Native Currency: USD 500,000)
Reason: We are looking for funds to build inventory, hire international sales managers, and conduct advertis... View More
Includes physical assets worth USD 5 million
Interested to connect with advisors
Name, Phone, Email
Available after connect
Business Name
Available after connect
User Verification
Documents
Business Overview

- Our year over year revenue growth has increased 700%.

- We are rapidly finalizing distribution agreements worldwide.

- Our year-over-year increase in the number of our distributors is 600%.

- Our technology is more cost-effective than those of our competitors.

- We are the only vein finder medical device used on the front lines of Ukraine, treating the most severely wounded civilians and soldiers.

- Our patented IP, and our existing distributor network, have tremendous value.

- We have not yet found a patient, no matter how sick, where our device could not find veins.

Products & Services Overview

The Vein-Eye Carry is selling worldwide and has been accepted as the premier blood vessel illumination device, or vein finder. After we recognize revenue from this product, we will then develop other products using our unique and patented chipset. All of our products will be non-contact and non-invasive. They will include cancer screening, vein recognition biometrics, and our patented optical ultrasound tomography device, which will detect bleeding in the brain in real-time and at the scene of the injury. It will also send those images to a waiting neurosurgeon.

Assets Overview

Our main assets are our patented medical devices, inventory, high-quality distributors, ongoing and inceasing sales, our reputation as the premier gold standard in vein finding, and our partnerships with high-quality medical institutions.

Facilities Overview

Virtual offices in the USA, EU and MENA. We are owned, in part, by the City University of New York.

Capitalization Overview

We have begun our worldwide sales launch and we are seeing consistent growth and success. Funding to date has been from Mom and Pop investors, with no VCs. Our total debt is less than $200K.

Recent Activity
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business

14 Investors viewed this Business this week.
Register below to connect now!

Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses

    Frequently
    Asked
    Questions

    • Why can’t I see the business’ name or contact number? How do I contact the business?
    • What level of due diligence does SMERGERS conduct on the businesses/member?
    • How active are the business profiles listed on SMERGERS?
    • How does SMERGERS rate business profiles?
    • Do I need to pay to connect with a business?
    • Show more